News for 9 Meters Biopharma, Inc. (INNTW)

Humacyte has promising potential with FDA designations and a pending FDA approval decision for its ATEV product. Learn more about HUMA stock here.

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation's securities were

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.08%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.06%

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also rose, gaining, 0.46% to 4,543.70.

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to 14,190.20. The S&P 500, also fell, declining, 0.05% to 4,520.47.

According to Fortune Business Insights, Short Bowel Syndrome Market to Reach USD 2,213.5 million by 2029; Rising Awareness of Rare Diseases and the Growing...

Read Brookline Capital Management Reaffirms Buy Rating for 9 Meters Biopharma (NASDAQ:NMTR) at ETF Daily News

Read 9 Meters Biopharma (NASDAQ:NMTR) Reaches New 12-Month High at $3.65 at ETF Daily News

Read 9 Meters Biopharma’s (NMTR) “Buy” Rating Reaffirmed at Brookline Capital Management at ETF Daily News

In this article we are going to use hedge fund sentiment as a tool and determine whether Matrix Service Co (NASDAQ:MTRX) is a good investment right now.